TrialThe Journal of infectious diseases2022
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine.
Edward E Walsh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
65 papers cite itlatest 60 shown
this paperpooled ittrialcites it